Blog | Insights and Trends | Impulse Generator Fund

Blog

Stablecoin Summer Phase II: Fun Raises $72M for Crypto-Fiat Rails

Infrastructure for programmable money is now a permanent pillar of global finance. In May 2026, the fintech firm Fun secured a $72M Series A round. This funding allows them to scale an API-first bridge between banks and blockchain settlement. This raise confirms that “Stablecoin Summer” is not a temporary trend. Instead, it represents a fundamental […]

Blog

The Audit Era: Anthropic’s “Mythos” and the Security Gold Rush

Artificial Intelligence transitioned from a creative tool to a master auditor this quarter. In May 2026, Anthropic’s “Mythos” model began identifying critical vulnerabilities in global financial systems that remained hidden for decades. This development triggered a massive wave of enterprise concern and a corresponding surge in cybersecurity investment. At IGF (Impulse Generator Fund), we recognize […]

Blog

Agent-Only Futures: Why OpenAI is Killing the Traditional App

The “App Store” era reached its sunset in May 2026. OpenAI initiated a total pivot toward an “Agent-Only” future. This strategic shift moves the industry away from manual user interfaces. Instead, it prioritizes autonomous task completion through Large Action Models (LAMs). Previously, users acted as the “glue” between different applications. They had to open multiple […]

Blog

Warehouse robot representing physical AI and robotics 2026 trends for high-potential ventures.

Physical AI and Robotics 2026: Moving Atoms

For the last decade, the tech world has focused almost entirely on “moving bits.” In 2026, the focus has shifted toward “moving atoms” in the real world. Physical AI and robotics 2026 trends show a massive shift in where capital is being deployed. Persistent labor shortages across the globe drive this industrial change. Consequently, breakthroughs […]

Blog

Molecular rendering showing the Eli Lilly Kelonia Therapeutics acquisition technology.

Eli Lilly Kelonia Therapeutics Acquisition: A Biotech Revolution

AI-generated medicine is currently delivering some of the largest exits in the tech world. The Eli Lilly Kelonia Therapeutics acquisition is the latest and most impressive example. Eli Lilly paid a total of $7 billion for the innovative startup. Kelonia rose from stealth mode to a multi-billion-dollar exit in under five years. This success proves […]

Blog

Eli Lilly Kelonia Therapeutics Acquisition: A Biotech RevolutionAI-generated medicine is currently delivering some of the largest exits in the tech world. The Eli Lilly Kelonia Therapeutics acquisition is the latest and most impressive example. Eli Lilly paid a total of $7 billion for the innovative startup. Kelonia rose from stealth mode to a multi-billion dollar exit in under five years. This success proves that AI-driven modeling permanently compresses the traditional 15-year biotech development timeline.Compressing the Time-to-ValueKelonia’s success lies in its use of "in vivo" engineering and AI drug discovery models. According to the official Kelonia press release, the acquisition expands Lilly's genetic medicine capabilities significantly. The team skipped several years of expensive trial-and-error in the lab. Lilly paid $3.25 billion of the total upfront to secure this technology.This Eli Lilly Kelonia Therapeutics acquisition clearly shows that Big Pharma is hungry for high-velocity R&D engines. At IGF, we provide the thorough due diligence and strategic guidance needed for investors to identify such high-potential ventures. They are no longer just buying individual drugs. They are buying the AI platforms that can generate dozens of treatments. Furthermore, this approach reduces the risk of failure in clinical trials by simulating results before they happen.The New Liquidity MilestoneInvestors no longer have to wait twenty years for a clinical trial to conclude. If the AI model is sufficiently predictive, an exit can happen in the early clinical phases. Therefore, this high-velocity model will soon influence every technical industry. We help our startup partners use similar data management standards to ensure precision and reliability in their products.AI effectively removes the distance between an initial idea and a viable market solution. This Eli Lilly Kelonia Therapeutics acquisition is just the beginning of a larger wave. As more pharmaceutical giants adopt AI, the cost of medicine could eventually drop. Consequently, the speed of human health improvement will increase. IGF is proud to support the technical innovation that makes these medical breakthroughs possible.SEO Metadata:Focus Keyphrase: Eli Lilly Kelonia Therapeutics acquisitionSEO Title: Eli Lilly Kelonia Therapeutics Acquisition: AI Biotech ExitsMeta Description: The Eli Lilly Kelonia Therapeutics acquisition hit $7B. See how AI-driven discovery is compressing 15-year biotech timelines into fast exits.Slug: eli-lilly-kelonia-acquisition-biotech-aiImage Alt Text: Molecular rendering showing the Eli Lilly Kelonia Therapeutics acquisition technology.6. Physical AI and Robotics 2026: Moving AtomsFor the last decade, the tech world focused almost entirely on "moving bits." In 2026, the focus has shifted toward "moving atoms" in the real world. Physical AI and robotics 2026 trends show a massive shift in where capital is being deployed. Persistent labor shortages across the globe drive this industrial change. Consequently, breakthroughs in robotics foundation models are now attracting billions in venture capital.Automating the Global Supply ChainCompanies like Skild AI recently raised a massive $1.4 billion in funding. They are building what experts call a "general-purpose robot brain." As reported by Humanoids Daily, the Skild Brain is an "omni-bodied" model that can control various mechanical forms. Furthermore, companies like Waymo are expanding their autonomous fleets rapidly to automate the entire supply chain.Physical AI and robotics 2026 developments help firms achieve 50% productivity gains in their fulfillment centers. Furthermore, these robots are becoming more capable of handling delicate tasks. Today, they can pick and pack fragile items with human-like precision. IGF supports these transitions by providing the technical expertise and international support required for high-growth scaling in physical environments.The Industrial Robotics BoomInvestors now prioritize technology that can perceive, reason, and act in the physical world. Robotics investment has doubled in Europe recently. For e-commerce founders, this technology is the final piece of the automation puzzle. We help brands prepare for an autonomous fulfillment loop through our solution architecture design.The future of commerce is a seamless path from the initial click to the final delivery. By integrating physical AI and robotics 2026 trends, brands can reduce their shipping times significantly. Furthermore, autonomous delivery vehicles are becoming common in urban areas. This reduces traffic and lowers the carbon footprint of every order. Consequently, the businesses that embrace "moving atoms" will own the physical infrastructure of the future. IGF is here to help you transform these visionary ideas into scalable products.SEO Metadata:Focus Keyphrase: physical AI and robotics 2026SEO Title: Physical AI and Robotics 2026: Why We Are Now Moving AtomsMeta Description: Physical AI and robotics 2026 are transforming the market. Learn how Skild AI and Waymo are building the brains for a global supply chain.Slug: physical-ai-robotics-supply-chain-2026Image Alt Text: Warehouse robot representing physical AI and robotics 2026 trends for high-potential ventures.

Shield AI $12.7B Valuation: The Rise of Defense Tech

Defense Technology has officially become a blue-chip asset class for venture capital. Shield AI recently secured $2 billion in new funding from major investors like Advent International. This pushed the Shield AI $12.7B valuation into the global spotlight. This investment focuses heavily on software capabilities rather than just physical hardware. Their AI systems govern autonomous […]